1
Clinical Trials associated with Lianbizhi For Injection / Not yet recruitingPhase 1 [Translation] Phase I clinical human tolerance trial of Lianbizhi injection
选择健康人为受试者,从安全的初始剂量开始,观察人体对注射用莲必治的耐受性,探索人体可耐受的剂量,了解在此剂量下可能出现的不良反应,为制定本品的Ⅱ期临床试验给药方案提供安全的剂量范围。
[Translation] Healthy people were selected as subjects, starting from a safe initial dose, to observe the human body's tolerance to Lianbizhi for injection, explore the dose that the human body can tolerate, understand the adverse reactions that may occur at this dose, and provide a safe dosage range for formulating the dosing regimen for the Phase II clinical trial of this product.
100 Clinical Results associated with Lianbizhi For Injection
100 Translational Medicine associated with Lianbizhi For Injection
100 Patents (Medical) associated with Lianbizhi For Injection
100 Deals associated with Lianbizhi For Injection